How do you decide in those patients in whom you believe combination T4/T3 therapy may be beneficial, whether you add T3 to T4 monotherapy or whether you commit you patients to DTE as the primary strategy for combination therapy?

Name: How do you decide in those patients in whom you believe combination T4/T3 therapy may be beneficial, whether you add T3 to T4 monotherapy or whether you commit you patients to DTE as the primary strategy for combination therapy?
Uploaded: T00:00:00+00:00
Description: How do you decide in those patients in whom you believe combination T4/T3 therapy may be beneficial, whether you add T3 to T4 monotherapy or whether you commit you patients to DTE as the primary strategy for combination therapy?

CLICK HERE FOR CME CREDIT Back to Symposium

Created by

Presenter

CAPT(ret) Thanh D. Hoang, DO, MACP, FACE

Professor of Medicine, Uniformed Services University of the Health SciencesDirector, Endocrinology Division, Uniformed Services University of the Health Sciences Walter Reed National Military Medical CenterEndocrinology, Diabetes & MetabolismBethesda, MD